Adaptive Biotechnologies Corporation (ADPT) Q4 2019 Earnings Results

Adaptive Biotechnologies Misses on EPS, Stock Down 1.17%

The earnings report from Adaptive Biotechnologies showed a loss per share of $0.17, but no revenue figures were provided. The stock fell by 1.17% following the announcement, likely due to the absence of guidance and clarity on future performance. Investors may be cautious as they await more information on the company's direction.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.17	N/A	N/A
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Neutral

Management's commentary was limited, with no specific details on revenue or future expectations. The lack of guidance may leave investors uncertain.

Management did not provide specific insights into revenue performance.

No guidance was offered for future quarters.

Adaptive Biotechnologies Misses on EPS, Stock Down 1.17%

Key numbers

Management commentary

Adaptive Biotechnologies Corporation

More earnings this week

Adaptive Biotechnologies Misses on EPS, Stock Down 1.17%

Key numbers

Management commentary